Loading
4P Pharma
  • 4P-Pharma
    • About Us
    • Our Team
  • Pipeline
    • Overview
    • Osteoarthritis
    • COVID-19
    • Stimulant Use Disorders
    • Neurodegenerative Diseases
  • Partnerships
    • Our Business Model
    • Our Partners
  • News
  • Contact Us
  • Search
  • Twitter
  • Linkedin

News & Events

News & Events

4P-Pharma at BIO International Convention 2019

4P-Pharma’s CEO, Revital Rattenbach, will be attending the upcoming BIO International Convention 2019 in Philadelphia (USA), June 3-6, 2019.

To learn more about our pipeline and discuss future collaborations, contact us via the partnering platform or by e-mail.

4P-Pharma_BIO2019

05/21/2019/by admin
Tags: 4p-pharma, B2B meeting, BIO2019, biotech
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on Linkedin
  • Share by Mail
You might also like
4P-Pharma is in the "50 Fastest Growing Companies of the Year 2020”
4P-Pharma à Parcours France 2018
4P-Pharma will attend the 10th DDIP, November 28th-29th 2019 - Barcelona, Spain
4p-pharma linkedin 4P Pharma on LinkedIn
4P-Pharma at the Biotech Showcase 2021 online
4P-Pharma est dans Biotech Finances
4P-Pharma est dans La Voix Du Nord
4P-Pharma at Human Biotech & Animal Health Business Partnering Summit 2019

Sitemap

  • 4P-Pharma
  • Pipeline
  • Partnerships
  • Contact Us
  • Legal Mention

Latest Tweets from 4P Pharma

Tweets de @4P_Pharma

Contact us

Campus de l’Institut Pasteur de Lille 1 Rue du Professeur Calmette 59000 Lille, France
+33 9 50 72 97 68 …

Latest News

  • 4P-Pharma at the Biotech Showcase 2021 online01/07/2021 - 12:44 PM
  • Happy New Year 2021 !01/06/2021 - 12:02 PM
  • 4Moving Biotech au congrès de la SFR12/08/2020 - 12:39 PM
Followon TwitterSubscribeto RSS Feed
© Copyright - 4P-Pharma | Programming: Roy Eyal Studio | Design: Liora Schirer Studio
  • Twitter
  • Linkedin
  • 4P-Pharma
  • Pipeline
  • Partnerships
  • Contact Us
  • Legal Mention
4P-Pharma at Human Biotech & Animal Health Business Partnering Summit ... 4P-Pharma dans le dossier Spécial Biotech du journal Le Point
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
Scroll to top